Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Exhaled Breath Aerosol Collection Devices in Patients With Lower Respiratory Tract Infection - a Performance and Acceptability Study (Acronym: AeroCAP)

NCT06668883 is registered in ClinicalTrials.gov with Avelo AG as lead sponsor.

NCT NCT06668883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06668883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Exhaled Breath Aerosol Collection Devices in Patients With Lower Respiratory Tract Infection - a Performance and Acceptability Study (Acronym: AeroCAP)
Lead sponsor
Avelo AG
Phase
Observational
Overall status
Completed
Start date
November 13, 2024
Completion date
May 21, 2025
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower respiratory tract infection (lrti), pneumonia